Meral A. Cıblak

Incidence of Bloodstream Infections Due to <i>Candida</i> Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

Rana Hajjeh, André N. Sofair, Lee H. Harrison et al. · Journal of Clinical Microbiology · 2004 · 649 citations · Full text

Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study

Saverio Caini, Q. Sue Huang, Meral A. Cıblak et al. · Influenza and Other Respiratory Viruses · 2015 · 197 citations · Full text

In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against <i>Blastomyces dermatitidis</i> , <i>Coccidioides immitis</i> , and <i>Histoplasma capsulatum</i>

Renkai Li, Meral A. Cıblak, Nicole G. Nordoff et al. · Antimicrobial Agents and Chemotherapy · 2000 · 194 citations · Full text

Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing <i>Candida</i> Isolates

Beth A. Arthington‐Skaggs, Wendy Lee‐Yang, Meral A. Cıblak et al. · Antimicrobial Agents and Chemotherapy · 2002 · 159 citations · Full text

Diagnostic Mycology, Mic End Points, Bioanalysis +17

Comparative Evaluation of NCCLS M27-A and EUCAST Broth Microdilution Procedures for Antifungal Susceptibility Testing of Candida Species

Manuel Cuenca‐Estrella, Wendy Lee‐Yang, Meral A. Cıblak et al. · Antimicrobial Agents and Chemotherapy · 2002 · 131 citations · Full text

Antifungal Agent, Antimicrobial Susceptibility, Nccls M27-a +12